Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTX · Real-Time Price · USD
19.39
-0.69 (-3.44%)
At close: Oct 19, 2026, 4:00 PM EDT
19.46
+0.07 (0.36%)
After-hours: Oct 19, 2026, 7:30 PM EDT
Scribe Therapeutics Market Cap
Scribe Therapeutics has a market cap or net worth of $367.09 million as of October 19, 2026. It is the 16,813th most valuable company in the world and the 2,972nd biggest in the United States.
Market Cap
367.09M
Enterprise Value
367.35M
1-Year Change
n/a
Global Rank
Country Rank
#2,972 United States
Category
ChartMarket Cap Chart
Since the IPO on July 24, 2026, Scribe Therapeutics's market cap has increased from $242.73M to $367.09M, an increase of 51.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 367.09M | -3.44% |
| Oct 16, 2026 | 380.15M | -3.09% |
| Oct 15, 2026 | 392.26M | -0.24% |
| Oct 14, 2026 | 393.21M | 8.63% |
| Oct 13, 2026 | 361.97M | -7.50% |
| Oct 12, 2026 | 391.32M | -2.36% |
| Oct 9, 2026 | 400.78M | 10.09% |
| Oct 8, 2026 | 364.06M | 9.45% |
| Oct 7, 2026 | 332.63M | 7.59% |
| Oct 6, 2026 | 309.15M | 0.74% |
| Oct 5, 2026 | 306.88M | -3.45% |
| Oct 2, 2026 | 317.86M | -2.24% |
| Oct 1, 2026 | 325.15M | -6.68% |
| Sep 30, 2026 | 348.44M | -20.08% |
| Sep 29, 2026 | 436.00M | 5.79% |
| Sep 28, 2026 | 412.14M | 2.30% |
| Sep 25, 2026 | 402.87M | -1.53% |
| Sep 24, 2026 | 409.11M | -18.55% |
| Sep 23, 2026 | 502.26M | -5.49% |
| Sep 22, 2026 | 531.41M | 0.07% |
| Sep 21, 2026 | 531.03M | -15.00% |
| Sep 18, 2026 | 624.75M | 2.68% |
| Sep 17, 2026 | 608.46M | 10.45% |
| Sep 16, 2026 | 550.91M | -8.09% |
| Sep 15, 2026 | 599.38M | 7.61% |
| Sep 14, 2026 | 556.97M | -1.08% |
| Sep 11, 2026 | 563.03M | 0.92% |
| Sep 10, 2026 | 557.92M | 0.20% |
| Sep 9, 2026 | 556.78M | -6.16% |
| Sep 8, 2026 | 593.32M | 9.31% |
| Sep 4, 2026 | 542.77M | -6.95% |
| Sep 3, 2026 | 583.29M | -0.29% |
| Sep 2, 2026 | 584.99M | 6.93% |
| Sep 1, 2026 | 547.07M | -5.04% |
| Aug 31, 2026 | 576.12M | 7.38% |
| Aug 28, 2026 | 536.50M | -1.39% |
| Aug 27, 2026 | 544.05M | -9.02% |
| Aug 26, 2026 | 598.00M | 1.59% |
| Aug 25, 2026 | 588.66M | -16.23% |
| Aug 24, 2026 | 702.70M | 9.14% |
| Aug 21, 2026 | 643.84M | 3.96% |
| Aug 20, 2026 | 619.32M | 5.73% |
| Aug 19, 2026 | 585.74M | 14.53% |
| Aug 18, 2026 | 511.41M | 27.94% |
| Aug 17, 2026 | 399.74M | 2.22% |
| Aug 14, 2026 | 391.06M | 1.77% |
| Aug 13, 2026 | 384.27M | -11.47% |
| Aug 12, 2026 | 434.07M | -1.83% |
| Aug 11, 2026 | 442.18M | -5.98% |
| Aug 10, 2026 | 470.29M | -4.12% |
| Aug 7, 2026 | 490.47M | 2.32% |
| Aug 6, 2026 | 479.34M | 6.76% |
| Aug 5, 2026 | 448.97M | 7.89% |
| Aug 4, 2026 | 416.15M | 5.88% |
| Aug 3, 2026 | 393.04M | 6.96% |
| Jul 31, 2026 | 367.48M | -4.51% |
| Jul 30, 2026 | 384.83M | 11.11% |
| Jul 29, 2026 | 346.35M | 1.66% |
| Jul 28, 2026 | 340.69M | -4.80% |
| Jul 27, 2026 | 357.86M | 47.43% |
| Jul 24, 2026 | 242.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 407.77M |
| Tectonic Therapeutic | 403.69M |
| ProKidney | 402.09M |
| Eikon Therapeutics | 401.90M |
| ARS Pharmaceuticals | 399.78M |
| Capricor Therapeutics | 390.11M |
| TRex Bio | 377.18M |
| Rezolute | 375.53M |